Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Arteris (AIP) over the last 3 years, with Q3 2025 value amounting to $33000.0.

  • Arteris' Gains from Investment Securities fell 9323.77% to $33000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 3198.66%. This contributed to the annual value of $1.6 million for FY2024, which is 5424.53% down from last year.
  • As of Q3 2025, Arteris' Gains from Investment Securities stood at $33000.0, which was down 9323.77% from $372000.0 recorded in Q2 2025.
  • Arteris' Gains from Investment Securities' 5-year high stood at $2.8 million during Q4 2023, with a 5-year trough of -$31000.0 in Q1 2024.
  • For the 3-year period, Arteris' Gains from Investment Securities averaged around $554090.9, with its median value being $297000.0 (2023).
  • In the last 5 years, Arteris' Gains from Investment Securities crashed by 11043.77% in 2024 and then surged by 521428.57% in 2025.
  • Over the past 3 years, Arteris' Gains from Investment Securities (Quarter) stood at $2.8 million in 2023, then tumbled by 61.53% to $1.1 million in 2024, then crashed by 96.97% to $33000.0 in 2025.
  • Its Gains from Investment Securities was $33000.0 in Q3 2025, compared to $372000.0 in Q2 2025 and $746000.0 in Q1 2025.